Never knew you two were that iterested in blood, Hemoglobinopathies and Thalassemias anyone? Well let me tell you about it
I. Introduction
These conditions comprise a very large number of genetic biochemical/ physiological entities, most of which are academic curiosities whose major effect on medicine is to add to the surfeit of useless scientific information. However, several of these conditions (e.g., sickle cell anemia, hemoglobin SC disease, and some thalassemias) are common major life-threatening diseases, and some others (e.g., most thalassemias, hemoglobin E disease, and hemoglobin O disease) are conditions that produce clinically noticeable -- if not serious -- effects and can cause the unaware physician a lot of frustration and the hapless patient a lot of expense and inconvenience. We will study a few hemoglobinopathies and thalassemias of special importance. It should be kept in mind, though, that there are literally hundreds of diseases in these categories.
II. Definitions
Hemoglobinopathy: A genetic defect that results in abnormal structure of one of the globin chains of the hemoglobin molecule. Although the suffix "-pathy" would conjure an image of "disease," most of the hemoglobinopathies are not clinically apparent. Others produce asymptomatic abnormal hematologic laboratory findings. A very few produce serious disease. The genetic defect may be due to substitution of one amino acid for another (as with the very common Hb S and Hb C and the great majority of the other abnormal hemoglobins), deletion of a portion of the amino acid sequence (Hb Gun Hill), abnormal hybridization between two chains (Hb Lepore), or abnormal elongation of the globin chain (Hb Constant Spring). The abnormal chain that results may be the chain (Hb GPhiladelphia), chain (Hb S, Hb C), chain (Hb FTexas), or chain (Hb A2Flatbush). These abnormal hemoglobins can have a variety of physiologically significant effects, discussed below in greater depth, but the most severe hemoglobinopathies (Hb S and Hb C diseases) are characterized by hemolysis.
Thalassemia: A genetic defect that results in production of an abnormally low quantity of a given hemoglobin chain or chains. The defect may affect the , , , or chain, or may affect some combination of the , , and chain in the same patient (but never the and chain together). The result is an imbalance in production of globin chains and the production of an inadequate number of red cells. The cells which are produced are hypochromic/microcytic and contain a surfeit of the unaffected chains which cannot stoichiometrically "mate" with the inadequate supply of thalassemic chains. These "bachelor" chains can produce adverse effects on the red cell and lead to destruction of the red cell in the marrow (ineffective erythropoiesis) and in the circulation (hemolysis). Note that these two definitions are not mutually exclusive -- some hemoglobinopathies may also be thalassemias, in that a structurally abnormal hemoglobin (hemoglobinopathy) may also be underproduced (thalassemia). Some, but not all, hemoglobinopathies and thalassemias are hemolytic anemias. These nosologic concepts are summarized by the Venn diagram below.
III. Pathophysiology of hemoglobinopathies
Messing around with the amino acid sequence of a globin chain has something of a red kryptonite effect. While some positions on the protein chain can tolerate a lot of substitutions without compromising the physiologic integrity of hemoglobin, other positions are very sensitive to amino acid substitutions. For instance, substitution of valine or lysine for glutamate at position 6 of the chain produces hemoglobins S and C, respectively, which form intraerythrocytic tactoids (see below) and crystals (again respectively) that cause premature destruction of the rbc (hemolysis). On the other hand, substitution of glutamate, asparagine, and threonine for lysine at position 59 of the chain produces, respectively, hemoglobins IHigh Wycombe, JLome, and JKaoshiung, all of which are physiologically indistinguishable from normal Hb A. Without venturing too deeply into tedious stereochemistry, we can say that abnormal globin structure can functionally manifest itself in one or more of the following ways:
Increased O2 affinity
These hemoglobins tend to result when mutations affect the portions of the amino acid sequence that compose 1) the regions of contact between and chains, 2) the C-terminal regions, and 3) the regions that form the pocket which binds 2,3-DPG. The hemoglobin eagerly scarfs up the O2 from the alveoli but then only stingily gives it up to the peripheral tissues. The kidney, always compulsively vigilant for hypoxia, cranks out the erythropoietin thinking that a few extra red cells might help out matters. Erythropoiesis then is stimulated, even though there is no anemia, and erythrocytosis (increased total body rbc mass, increased blood hemoglobin concentration, increased hematocrit) is the result.
It is important to know that these rare increased O2 affinity hemoglobins exist to prevent diagnostic errors from occurring in working up patients presenting with erythrocytosis (which is much more commonly caused by other conditions, including polycythemia vera [a neoplasm], cigarette smoking, psychosocial stress, chronic residence at high altitudes, and chronic lung disease). Examples of these include Hb Chesapeake and Hb JCapetown.
Decreased O2 affinity
This is the other side of the coin. These hemoglobins are reluctant to pick up O2 from the lung. The result is a decreased proportion of hemoglobin that is oxygenated at a given PO2. The remainder of the hemoglobin is, of course, deoxygenated and is blue. If the level of blue hemoglobin exceeds 5 g/dL in capillary blood, the clinical result is cyanosis, a bluish discoloration of skin and mucous membranes.
Again, it is important to know about these hemoglobins and keep them in the back of your mind when working up cases of cyanosis, a condition much more commonly caused by pulmonary dysfunction or right-to-left cardiovascular shunts. Examples of low O2 affinity hemoglobins include Hb Seattle, Hb Vancouver, and Hb Mobile.
Methemoglobinemia
These hemoglobins are a special class of low O2 affinity hemoglobin variants that are characterized by the presence of heme that contains iron in the ferric (Fe+++) oxidation state, rather than the normal ferrous (Fe++) state. These methemoglobins are all designated "Hb M" and further divided by the geographic site of their discovery, e.g., Hb MSaskatoon and Hb MKankakee. The affected patients have cyanosis, since the methemoglobin is useless in O2 binding.
Methemoglobinemia due to hemoglobinopathy should be distinguished from methemoglobinemia due to other causes, such as NADH-diaphorase deficiency. This enzyme is needed for the reduction (to heme) of metheme that accumulates as a result of normal metabolic processes. Congenital absence of NADH-diaphorase causes an accumulation of metheme, despite the fact that the structure of the globin chain is normal. Toxic methemoglobinemia occurs in normal individuals exposed to certain oxidizing drugs and other compounds in the environment, even though these individuals have normal hemoglobin structure and a normal complement of NADH-diaphorase. In such victims, the oxidizing power of the toxin overwhelms the normal antioxidant defenses.
Since methemoglobin is a brown pigment, patients with clinically severe methemoglobinemia have obviously brown blood. This observation allows one to make a clever and memorable diagnosis at the bedside during the patient's first venipuncture.
Unstable hemoglobin (Heinz body anemia)
Certain abnormalities in the globin chain sequence produce a hemoglobin that is intrinsically unstable. When the hemoglobin destabilizes, it forms up into erythrocyte inclusions called Heinz bodies. It is important to know that Heinz bodies are not visible in cells stained with the routine Wright stain. It is necessary for the cells to be stained with a supravital dye (such as brilliant cresyl blue, which can also be used to demonstrate reticulocytes) to be visible. These inclusions attach to the internal aspect of the rbc membrane and reduce the deformability of the cell and basically turn it into spleenfodder. The result is hemolytic anemia. All of these hemoglobins are rare; inheritance is autosomal dominant. Homozygotes have not been described. Examples of unstable hemoglobins are Hb Gun Hill, Hb Leiden, and Hb Köln.
Sickling and crystallization
These phenomena occur respectively in Hb S and Hb C, the most important of the abnormal hemoglobins. We will deal with these in greater depth next.
IV. Specific hemoglobinopathies
A. Hemoglobin S and sickle cell disease
1. Epidemiology and genetics
The Hb S gene is found primarily in populations of native tropical African origin (which include most African-Americans). The incidence of the gene in some African populations is as high as 40%; in African-Americans the incidence is 8%. The gene is also found with less frequency in non-Indo-European aboriginal peoples of India and in the Middle East. Rare cases have been reported in Caucasians of Mediterranean descent. The gene established itself in the tropical African population presumably because its expression in heterozygotes (sickle cell trait) affords some protection against the clinical consequences of Plasmodium falciparum infestation. Unfortunately, homozygous expression produces sickle cell disease, which is a chronic hemolytic anemia and vaso-occlusive condition that usually takes the life of the patient.
Hemoglobin S has the peculiar characteristic of expressing its biochemical instability by precipitating out of solution and forming up into long microtubular arrays called tactoids. The erythrocytes which contain the Hb S stretch around the tactoids to form the characteristic long, pointed, slightly curved cells called (with somewhat liberal imagination) "sickle cells." Only the deoxygenated form of Hb S (deoxy-Hb S) makes tactoids. The greater the proportion of Hb S in the cell, the greater is the propensity to sickle. Therefore, persons with 100% Hb S (being homozygotes) sickle under everyday conditions, while typical heterozygotes (who usually have about 30-40% Hb S) do not sickle except possibly under extraordinary physiologic conditions. Since Hb S is a chain mutation, the disease does not manifest itself until six months of age; prior to that time the Hb S is sufficiently "watered down" by Hb F (22), which of course has no chain.
In post-infancy individuals homozygous for the Hb S gene, 97+% of the hemoglobin is Hb S, the remainder being the normal minor hemoglobin, Hb A2 (22). Several coexisting genetic "abnormalities" (actually godsends) prevalent in African populaitons may ameliorate the course of the disease:
-thalassemia carriers (which comprise 20% of African-Americans!) have a lower MCHC than normal individuals. It has been suggested that a low MCHC is beneficial in decreasing the vaso-occlusive properties of sickled cells. These sickle cell patients live longer and have a milder disease than do non-thalassemic patients. Thalassemia is discussed in greater detail below.
Hereditary persistence of fetal hemoglobin (HPFH) has established itself in the black population and allows Hb F to so dilute the Hb S that sickling does not occur or is less prominent. In these people the Hb F gene does not "turn off" in infancy but persists indefinitely.
G-6-PD deficiency has been suggested as an ameliorative condition for sickle cell disease. This is controversial; the pathophysiologic basis of any such effect must be pretty obscure.
2. Clinical findings
Sickle cell anemia is a particularly bad disease in that not only is it a hemolytic anemia, but also a vaso-occlusive condition. The clinical findings can then be divided into one of these two groups:
a. Effects of chronic hemolysis
Anemia. Pretty much self-explanatory
Jaundice, due to rapid heme turnover and subsequent generation of bilirubin
Cholelithiasis. It has been classically taught that sickle cell patients are prone to the formation of calcium bilirubinate gallstones due to excess bilirubin secretion into the hepatobiliary tree.
Aplastic crisis. Many of us have brief episodes of marrow aplasia as a result of common viral infections. With a normal erythrocyte life span of 120 days, no anemia results from an unnoticed marrow shut-down of a few days. However, the sickle cell patients, with their markedly abbreviated rbc life span, can have a precipitous fall in hematocrit (and retic count) under such conditions. This may be life-threatening.
Hemolytic crisis. Most sickle cell patients establish a stable, tonic level of hemolysis. Rarely, for obscure reasons, they experience a catastrophic fall in hematocrit, increasing intensity of jaundice, and increasing reticulocyte count. This is called a "hemolytic crisis."
b. Effects of vaso-occlusion
Dactylitis. Resulting presumably from infarction or ischemia of the bones of the hands and feet, this is often the presenting manifestation of sickle cell disease in a six-months-old infant. The hands and feet are swollen and painful.
Autosplenectomy. In childhood, the spleen is enlarged due to excess activity in destruction of the sickled erythrocytes. Gradually, the spleen infarcts itself down to a fibrous nubbin.
Priapism. This refers to a painful and sustained penile erection, apparently due to sludging of sickled cells in the corpora cavernosa. Sometimes the penis has to be surgically decompressed. Repeated episodes of priapism cause the spongy erectile tissues to be replaced by fibrous tissue, with impotence being the end result.
Renal papillary necrosis. The physiologic function of the loops of Henle make the renal medulla an eldritch, unbodylike area of high hematocrit, high osmolarity, low pH, hemodynamic stasis, and low PO2. All of these conditions predispose to sickling and infarctive loss of the papillae of the pyramids. The result is inability to concentrate and dilute urine. Even sickle cell trait individuals may experience episodes of hematuria, presumably due to this mechanism.
Infarctive (painful) crisis. Increased sickling activity may be brought about by any general stress on the body, especially infection. Almost any organ may suffer acute infarction (includinmg the heart), and pain is the chief symptom.
Sequestration crisis. This occurs mostly in infants and young children and is characterized by sudden pooling of sickled erythrocytes in the RES and vascular compartment. This produces a sudden fall in hematocrit. Sequestration crisis may be the most common cause of death in sickle cell patients in the youngest age group.
Leg ulcers. After all of the disasters mentioned above, this seems trivial. However, the deep, nonhealing ulcers of skin and tela subcutanea (classically around the medial malleolus) may be the only clinical manifestation of sickle cell disease in an otherwise well-compensated patient. These may be the only bugaboo standing between the patient and a productive, financially solvent life.